Dr. Judy Shizuru, Stanford University While stem cell and gene therapy research has advanced dramatically in recent years, many unknowns and questions remain about how best to use these approaches to develop therapies. Nineteen research programs awarded The governing Board of the California Institute for Regenerative Medicine (CIRM) has approved almost $25 million for 19 … Continue reading CIRM funds research on cancer and heart disease
Dr. Lili Yang
CIRM-Funded Study Advances Off-the-Shelf Cancer Immunotherapy
Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. Researchers have developed several forms of immunotherapy, including targeted antibodies, cancer vaccines, and cell-based therapies. These treatments have improved outcomes for many patients with aggressive cancers. However, most immunotherapies require personalized manufacturing. Scientists must create each treatment for an individual … Continue reading CIRM-Funded Study Advances Off-the-Shelf Cancer Immunotherapy
CIRM partners with UCLA scientists to take on COVID-19
Don't you love it when someone does your job for you and does it so well you have no need to add anything to it! Doesn't happen very often - sad to say - but this week our friends at UCLA wrote a great article describing the work they are doing to target COVID-19. Best … Continue reading CIRM partners with UCLA scientists to take on COVID-19
CIRM Board Approves Two New Discovery Research Projects for COVID-19
Dr. Karen Christman (left) and Dr. Lili Yang (right) This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new discovery research project as part of the $5 million in emergency funding for COVID-19 related projects. This brings the number of COVID-19 projects CIRM is supporting to 17, including three clinical trials. … Continue reading CIRM Board Approves Two New Discovery Research Projects for COVID-19